MA03.07 First-Line Atezolizumab Chemoimmunotherapy in Advanced Non-Squamous NSCLC Patients Harboring EGFR/ALK Genetic Alterations

Autor:	Thein, K. 1, Jahan, N. 2, Tun, A. 3, Sultan, A. 2, Swarup, S. 2, Mogollon-Duffo, F. 2, Yendala, R. 2, Quirch, M. 2, Htut, T. 4, D’Cunha, N. 2, Rehman, S. 2, Hardwicke, F. 2, Awasthi, S. 2, Tijani, L. 2
Zdroj:	In Journal of Thoracic Oncology October 2019 14(10) Supplement:S259-S259
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu